Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link between central fat and ...

Accropeutics’ drug has hit the goals of a phase 2 psoriasis trial in China, prompting the biotech to pledge to “accelerate” the TYK2/JAK1 inhibitor’s clinical development. The study saw ...

And if you’re anything like me (read: always curious about the latest wellness trend), you might be wondering whether light therapy has any actual benefits. To answer that question, we need to zoom ...

Nail problems affect nearly 10% of adults, with fungal infections outnumbering psoriasis cases by almost three to one. This prevalence disparity leads many people to automatically assume any nail ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

Patients with moderate to severe psoriasis treated with ustekinumab and guselkumab showed a trend towards a lower risk for herpes zoster (HZ) and postherpetic neuralgia (PHN) than those receiving ...

psoriasis and sun damage in a medical setting. But the at-home LED market is on the verge of becoming a massive industry - with masks and other devices retailing for anything from £40 to £1,500.

Pregnant women with psoriasis experienced significantly higher rates of preeclampsia/eclampsia and cardiac arrhythmias during delivery than women without psoriasis, in a study of a nationally ...

Psoriasis is a hereditary, chronic skin condition that can also result in inflammation of the joints. In Sweden, almost 300,000 people live with some form of the condition.